NYSE:CAHHealthcare
A Look At Cardinal Health (CAH) Valuation After Expanded Actinium-225 Cancer Therapy Production
Cardinal Health (CAH) is back in focus after expanding Actinium-225 production at its Center for Theranostics Advancement in Indianapolis. This move is aimed at supplying more material for investigational and future commercial cancer therapies.
See our latest analysis for Cardinal Health.
Recent news around Actinium-225 expansion and a board leadership change comes as Cardinal Health’s share price sits at US$214.05, with a 1-year share price return and a very large 5-year total shareholder...